Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-84.11M
↓ 73% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-48.76M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-84.11M | +5.7% |
| 2024 | $-89.20M | -32.7% |
| 2023 | $-67.24M | -105.9% |
| 2022 | $-32.66M | -101.8% |
| 2021 | $-16.18M | -410.9% |
| 2020 | $-3.17M | - |